Quarterly report pursuant to Section 13 or 15(d)

General (Details) - Schedule of Condensed Consolidated Statements of Operations

v3.24.3
General (Details) - Schedule of Condensed Consolidated Statements of Operations
$ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
Adaptive Phage therapeutics LLC [Member]  
Schedule of Condensed Consolidated Statements of Operations [Line Items]  
Net loss attributable to APT $ 5,884